This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
J Am Pharm Assoc (2003). Sign up today for our free Drug Topics newsletter. References 1. Osunsanmi O, Schmitz N, Darkwah B, et al. Time to goal hemoglobin A1c with pharmacist management compared to non-pharmacist management. 2025 May 6:102413. doi: 10.1016/j.japh.2025.102413. 2025.102413. Epub ahead of print. PMID: 40339647.
J Am Pharm Assoc (2003). I think a lot of pharmacists know that and even some of the ones who maybe aren't as quick to acknowledge it for whatever reason also recognize that.” References 1. Fick G, Osei J, Kim S, et al. A narrative literature review: Community pharmacy technician well-being and its implications. 2025 May 9:102419.
J Am Pharm Assoc (2003). READ MORE: Supporting the Well-Being of Community Pharmacy Technicians References 1. Fick G, Osei J, Kim S, et al. A narrative literature review: Community pharmacy technician well-being and its implications. 2025 May 9:102419. doi: 10.1016/j.japh.2025.102419. 2025.102419. Epub ahead of print. PMID: 40349976.
The term ‘psychedelic treatments’ incorporates a broad spectrum of different compounds, from LSD, psilocybin and DMT, to MDMA, ibogaine and ketamine. The latter compound has already been approved for treatment-resistance depression as the product Spravato (esketamine), after being developed by Janssen.
Yet the Food and Drug Administration (FDA) hasn’t approved this GLP-1 agonist injection for weight loss. Instead, it’s FDA approved to improve glycemic control in adults with Type 2 diabetes and to reduce the risk of adverse cardiovascular events in adults with Type 2 diabetes and known heart disease.
With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. This has been demonstrated recently with PLUVICTO ® , which was the first US Food and Drug Administration (FDA)-approved targeted radioligand therapy for eligible patients with prostate cancer.
Legislation passed in 2003 prohibits Medicare from covering drugs prescribed specifically for weight loss, and while Medicaid has more flexibility here, not every state will cover them. Look into compounded options (but be careful). Mounjaro’s only on-label use is for diabetes, so Medicaid likely won’t cover it for obesity.
1 More recently, regulators like the FDA have increasingly promoted the benefits of modeling (e.g., Topics in Chemical Engineering, 2003. Biopharma Adopts Mechanistic Modeling Mechanistic modeling has been widely used in the petrochemical industry for many decades, while biochemical producers have been slower to adopt. Melton, and E.
A 2003 law prohibits government-sponsored plans like Medicare from covering weight loss medication. Consider a compounded version For drugs on the Food and Drug Administration (FDA) shortage list, compounding pharmacies can create and sell copies, often at lower prices than the brand-name versions.
J Am Pharm Assoc (2003). J Am Pharm Assoc (2003). BMC Health Serv Res. 2005;5(1):3. doi:10.1186/1472-6963-5-3 6. Manzur V, Mirzaian E, Huynh T, et al. Implementation and assessment of a pilot, community pharmacy-based, opioid pain medication management program. 2020;60(3):497-502. doi:10.1016/j.japh.2019.11.029 2019.11.029 7.
Those began 20 years ago when he was involved in a major FDA inspection by Robert Tollefsen and Thomas Arista that significantly changed computer system validation in the industry. “As As a result, I was asked to present learning points and outcomes of that inspection at a GAMP Forum in San Francisco in January 2003.
Consistent with prior periods, Enbrel continued to lose market share, and this decline was compounded by a reduction in the growth rate of the rheumatology market as a result of COVID-19. Generally, these reviews are helpful when consumers research the product and read multiple reviews before buying it.
The Orange Book is the reference, and it allows the FDA to declare something [to be] therapeutically equivalent. The FDA Approval Process Within the FDA approval process, the 505(b)(1) new drug application (NDA) submission pathway is the pathway by which new drugs are able to seek approval.
J Am Pharm Assoc (2003). References 1. Fick G, Osei J, Kim S, et al. A narrative literature review: Community pharmacy technician well-being and its implications. 2025 May 9:102419. doi: 10.1016/j.japh.2025.102419. 2025.102419. Epub ahead of print. PMID: 40349976.
Additionally, quality control testing of these compounds is conducted using standard testing following applicable pharmacopeia—such as United States Pharmacopeia (USP), European Pharmacopeia (EP), and Japanese Pharmacopeia (JP)—that was current at the time of testing. Published February 2003. Published February 2003.
J Am Pharm Assoc (2003). link] August 21, 2024 Accessed June 11, 2025. Meyerson BE, Richter S, Gordon R, et al. Pharmacy harm reduction practices to help reduce opioid overdoses, Arizona 2023. 2025;65(3):102348. doi:10.1016/j.japh.2025.102348
J Am Pharm Assoc (2003). Am J Health Syst Pharm. 2019;76(4):251-253. doi:10.1093/ajhp/zxy040 13. Foster AA, Daly CJ, Logan T, et al. Implementation and evaluation of social determinants of health practice models within community pharmacy. 2022;62(4):1407-1416.doi:10.1016/j.japh.2022.02.005 doi:10.1016/j.japh.2022.02.005
Food and Drug Administration (FDA). Since atomoxetine treats attention-deficit hyperactivity disorder by being a selective norepinephrine reuptake inhibitor and since norepinephrine is an adrenaline compound, MAOIs are hazardous if taken concurrently or within 14 days of atomoxetine. MAOIs can lead to an increase in adrenaline.
For example, an assessment for a facility primarily focused on US and EU markets would only consider GMPs and regulations from EudraLex and the FDA. FDA CFR Title 21 Parts 211, 600, and 1271; 8. , FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing–Current Good Manufacturing Practice, 11.
J Am Pharm Assoc (2003). Perepelkin J, Antunes K, Boechler L, et al. Providing mindfulness meditation for patients with depression and anxiety in a community pharmacy: A pilot study. 2019 Mar-Apr;59(2):258-264. doi: 10.1016/j.japh.2018.10.017. 2018.10.017. Epub 2018 Dec 11. PMID: 30552050. Newsletter Pharmacy practice is always changing.
Since time immemorial, plants have been widely used as a source of medicinal compounds. However, upstream production in plants must also comply with additional laws relating to environmental release if grown outdoors (Directive 2001/ 18/EC, and 1829/2003/EC if the crop can be used as food/ feed) and Directive 2009/41EC if grown in constraint.
Not surprisingly, then-presidential candidate Asa Hutchinson, DEA Administrator from 2001 to 2003, did not sign the letter. FDA has not approved marijuana for medical use because no double-blind, published studies show safety and efficacy for raw marijuana. In other words, no rescheduling.
Just this year, the FDA approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia caused by chronic kidney disease, for adults who have been receiving dialysis for at least four months. [58] There are various iron salts, or compounds, and each of them have different levels of elemental iron in them. [63]
Bush’s Medicare Modernization Act (MMA) of 2003, and with it drug coverage for tens of millions of Medicare enrollees for the first time in program history. From a coverage perspective, Part D has been a success, with older Americans paying far less for drugs than they otherwise would have prior to MMA 2003. Add President Joseph R.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content